Harvard Bioscience Inc expected to post earnings of 10  cents a share - Earnings Preview

Harvard Bioscience

04/03/2022 15:38

* Harvard Bioscience Inc  HBIO.OQ   HBIO.O  is expected
to show a
rise in quarterly revenue when it reports  results on March 8. 
    * The Holliston Massachusetts-based  company is expected to
report
 a 6.4% increase in revenue to $32.963 million from $30.98
million a year ago, according to the mean estimate from 4
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Harvard Bioscience
Inc is
for earnings of 10 cents per share. For the same quarter last
year, the company reported earnings of 8 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Harvard
Bioscience Inc is $10​, about 45.8% above​ its last closing
price of $5.42. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2021  0.06        0.06       0.06      Met     0
 Jun. 30 2021  0.06        0.06       0.06      Met     -5.3
 Mar. 31 2021  0.03        0.03       0.05      Beat    50​
 Dec. 31 2020              0.07       0.08      Beat    23.1
 ​​Sep.        0.03        0.04       0.04      Met     14.3
 30 2020                                                
 Jun. 30 2020  -0.01       -0.01      0.05      Beat    600​
 Mar. 31 2020  0.03        0.03       -0.01     Missed  -130
 Dec. 31 2019  0.09        0.09       0.08      Missed  -7.7
 This summary was machine generated March 4 at 15:38 GMT.  All
figures in US dollars  unless otherwise stated